Arti Ahluwalia
Plus aucun poste en cours
Historique de carrière de Arti Ahluwalia
Anciens postes connus de Arti Ahluwalia
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| University of Pisa | Corporate Officer/Principal | - | - |
Tissue Engineering Technologies AG
 Tissue Engineering Technologies AG BiotechnologyHealth Technology Part of Lonza Group AG, Tissue Engineering Technologies AG is a German company that manufactures bacterial and virus vaccines, toxoids, and analogous products. The company is based in Reutlingen City, Germany. The company was founded in 2000 by Hugo Hämmerle. The CEO is Detlef Schumann. | Corporate Officer/Principal | - | - |
Kirkstall Ltd.
 Kirkstall Ltd. Pharmaceuticals: OtherHealth Technology Kirkstall Ltd. provides in vitro cell culture research and the development services. Its products include cancer research, stem cell research, disease modeling, drug discovery and advanced organ models. The company was founded by J. Malcolm Wilkinson, Garry P. Mumford, and Arti Ahluwalia on November 23, 2006 and is headquartered in Rotherham, the United Kingdom. | Directeur Technique/Scientifique/R&D | 23/06/2010 | 24/01/2014 |
| Fondateur | 23/11/2000 | - |
Statistiques
Internationale
| Royaume-Uni | 2 |
| Italie | 2 |
| Allemagne | 2 |
Opérationnelle
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Founder | 1 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Kirkstall Ltd.
Kirkstall Ltd. Pharmaceuticals: OtherHealth Technology Kirkstall Ltd. provides in vitro cell culture research and the development services. Its products include cancer research, stem cell research, disease modeling, drug discovery and advanced organ models. The company was founded by J. Malcolm Wilkinson, Garry P. Mumford, and Arti Ahluwalia on November 23, 2006 and is headquartered in Rotherham, the United Kingdom. | Health Technology |
Tissue Engineering Technologies AG
Tissue Engineering Technologies AG BiotechnologyHealth Technology Part of Lonza Group AG, Tissue Engineering Technologies AG is a German company that manufactures bacterial and virus vaccines, toxoids, and analogous products. The company is based in Reutlingen City, Germany. The company was founded in 2000 by Hugo Hämmerle. The CEO is Detlef Schumann. | Health Technology |
- Bourse
- Insiders
- Arti Ahluwalia
- Expérience
